Clinical and Urodynamic Evaluation of Surgical Repair of Pelvic Organ Prolapse Associated With Lower Urinary Tract Symptoms
1 other identifier
interventional
83
0 countries
N/A
Brief Summary
To assess the urinary symptoms and urodynamic findings concomitant with Pelvic organ prolapse before and after surgical treatment and to define the role of urodynamic study in treatment decision making.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Dec 2014
Typical duration for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 9, 2021
CompletedFirst Posted
Study publicly available on registry
March 11, 2021
CompletedMarch 11, 2021
March 1, 2021
1.6 years
March 9, 2021
March 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Urodynamic study evaluation for the participants
evaluation of the urodynamic study after the surgical repair of the pelvic organ prolapse and comparison to the preoperative results.
6 month after the procedure
Interventions
comparison between the urodynamic study of the patients before pelvic prolapse surgical repair and 6 months later.
Eligibility Criteria
You may qualify if:
- women with anterior pelvic organ prolapse (POP) associated with Lower urinary tract symptoms
You may not qualify if:
- Patients with POP less than POP-Q grade II, POP not in need for surgical repair, neurological diseases that could possibly affect voiding functions, pelvic infections, congenital bladder disorders, history of urinary fistula, history of malignancy, and patients on current medical treatment for voiding dysfunction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
March 9, 2021
First Posted
March 11, 2021
Study Start
December 1, 2014
Primary Completion
July 1, 2016
Study Completion
December 1, 2018
Last Updated
March 11, 2021
Record last verified: 2021-03